Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BLU NYSE:CGI BATS:IGV On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLUBELLUS Health$14.74$14.62$6.38▼$14.76$1.87B0.193.08 million shs3.45 million shsCGICeladon Group$3.45$0.00$1.30▼$8.52N/AN/A405,719 shsN/AIGViShares Expanded Tech-Software Sector ETF$106.56+9.4%$109.34$75.96▼$112.59$7.70B1.154.89 million shs4.79 million shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLUBELLUS Health0.00%0.00%0.00%0.00%0.00%CGICeladon Group0.00%0.00%0.00%0.00%0.00%IGViShares Expanded Tech-Software Sector ETF+0.34%+0.97%-1.42%+4.86%+27.98%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBLUBELLUS HealthN/AN/AN/AN/AN/AN/AN/AN/ACGICeladon GroupN/AN/AN/AN/AN/AN/AN/AN/AIGViShares Expanded Tech-Software Sector ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLUBELLUS Health 0.00N/AN/AN/ACGICeladon Group 0.00N/AN/AN/AIGViShares Expanded Tech-Software Sector ETF 2.71Moderate Buy$106.56N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLUBELLUS Health$15K124,613.93N/AN/A$3.09 per share4.77CGICeladon GroupN/AN/AN/AN/AN/AN/AIGViShares Expanded Tech-Software Sector ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLUBELLUS Health-$76.08M-$0.72N/AN/AN/A-578,586.63%-24.27%-23.14%N/ACGICeladon GroupN/AN/A0.00∞N/AN/AN/AN/AN/AIGViShares Expanded Tech-Software Sector ETFN/AN/A45.14∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBLUBELLUS HealthN/AN/AN/AN/AN/ACGICeladon Group$0.020.58%N/AN/AN/AIGViShares Expanded Tech-Software Sector ETFN/A0.45%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLUBELLUS HealthN/A33.4233.42CGICeladon GroupN/AN/AN/AIGViShares Expanded Tech-Software Sector ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLUBELLUS Health90.37%CGICeladon Group86.08%IGViShares Expanded Tech-Software Sector ETFN/AInsider OwnershipCompanyInsider OwnershipBLUBELLUS Health24.17%CGICeladon Group3.82%IGViShares Expanded Tech-Software Sector ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBLUBELLUS Health74126.81 million96.16 millionNot OptionableCGICeladon GroupN/AN/AN/ANot OptionableIGViShares Expanded Tech-Software Sector ETFN/A111.55 millionN/ANot OptionableIGV, MRCH, BLU, and CGI HeadlinesRecent News About These CompaniesSalesforce upgraded to Neutral at DA Davidson following underperformanceAugust 16 at 8:55 PM | msn.comShould You Invest in the iShares Expanded Tech-Software Sector ETF (IGV)?August 11, 2025 | zacks.com'Fast Money' traders talk trading the tech divergenceJuly 10, 2025 | youtube.comYIGV: Software Names Nearing Another Key Breakout, Monitoring The P/EJune 23, 2025 | seekingalpha.com3 Tech Focused ETFs to Watch as the Market Nears All-Time Highs (IGV)...June 11, 2025 | marketbeat.comShould You Invest in the iShares Expanded Tech-Software Sector ETF (IGV)?June 11, 2025 | zacks.comLooking for Exposure to Salesforce Stock (NYSE:CRM)? Try These Two ETFsMay 10, 2025 | theglobeandmail.comForget 'Sell in May': 5 Factors Why Wall Street ETFs Could Rally AheadMay 5, 2025 | zacks.comIGV: Software Tariff Immunity, Robust Growth, Valuation Plunge Provide Buying OpportunityApril 14, 2025 | seekingalpha.comShould You Invest in the iShares Expanded Tech-Software Sector ETF (IGV)?April 10, 2025 | zacks.comIGV: Play the Next Phase of the AI Movement With This ETF...March 13, 2025 | marketbeat.comWall Street Bloodbath: Use It to Buy These ETFsMarch 11, 2025 | zacks.comTech Sector ETFs Set to Rule Under Trump's Second Term?February 21, 2025 | msn.comSoftware Stocks Are Surging. Why the Gains Should Keep Coming.February 7, 2025 | msn.comShould You Invest in the iShares Expanded Tech-Software Sector ETF (IGV)?February 5, 2025 | zacks.comIGV: A Fund Safe From The StormsFebruary 3, 2025 | seekingalpha.comUnderstanding Sector-Specific ETFs: Opportunities in Tech, Energy, and HealthcareJanuary 31, 2025 | easternherald.comEWhat Happened to AI Stocks? Buy These InsteadJanuary 29, 2025 | msn.comEarnings Season: Big Roster of Tech Results AheadJanuary 23, 2025 | etftrends.comETrading (IGV) With Integrated Risk ControlsJanuary 19, 2025 | news.stocktradersdaily.comN5 Top-Ranked ETFs to Buy CheapJanuary 9, 2025 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesWhy the American Eagle Stock Rally Isn't Just Speculation By Gabriel Osorio-Mazilli | July 28, 20253 Companies That Will Profit From Trump's Semiconductor TariffsBy Jordan Chussler | August 14, 20253 Stocks Riding the AI Data Center Buildout WaveBy Chris Markoch | August 6, 20253 Short Squeeze Candidates With Big Catalysts on the HorizonBy Dan Schmidt | July 25, 2025PEGA Surges 14%: There's Still Time to Ride This GenAI InnovatorBy Leo Miller | July 27, 2025IGV, MRCH, BLU, and CGI Company DescriptionsBELLUS Health NASDAQ:BLUBELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada. As of June 28, 2023, BELLUS Health Inc. operates as a subsidiary of GSK plc.Celadon Group NYSE:CGICeladon Group, Inc. operates as a dry van truckload carrier, which transports full trailer loads of freight from origin to destination without intermediate stops or handling. The company offers time sensitive transportation in and between the U.S. and its two trading partners, Mexico and Canada. It operates through the following business segments: Asset-Based and Asset-Light. The Asset-Based segment includes its asset-based dry van carrier and rail services, which provide truckload carrier services of general commodities to a similar class of customers. The Asset-Light segment consists of its warehousing, brokerage, and less-than-load operations. Celadon Group was founded by Stephen B. Russell in May 1985 and is headquartered in Indianapolis, IN.iShares Expanded Tech-Software Sector ETF BATS:IGV$106.56 +9.15 (+9.39%) Closing price 03:59 PM EasternExtended Trading$106.42 -0.13 (-0.12%) As of 05:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.iShares North American Tech-Software ETF (the Fund), formerly iShares S&P North American Technology-Software Index Fund, is an exchange-traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the S&P North American Technology Software Index (the Underlying Index). The Underlying Index measures the performance of United States-traded stocks of software-related companies in the United States and Canada. The Underlying Index includes companies that are producers of client/server applications, enterprise software, application software, personal computers and home entertainment software. The Fund’s investment advisor is BlackRock Fund Advisors. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Medtronic: The Opportunity Gets Healthier for Income Investors Palo Alto Networks Uptrend Confirmed! New Highs Set by Year’s End Micron Stock Still Cheap Despite 25% Rally, Analysts Say Qualcomm Just Passed 1 Major Test, But Can It Pass the Next? Lyft's Billion-Dollar Signal: Why Wall Street Is Betting Big Joby Aviation: Why a Historic Flight Outweighs Analyst Downgrades Buy, Sell, or Hold? Insiders Pile Into These 3 Healthcare Stocks Grab Holdings: Get a Grip Now—Explosive Upside Brewing Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access